An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining discount codes.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.
Understanding The Experimental Drug
This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Healthcare Experts Express Worries
Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Elimination
Based on TikTok, the service has taken down problematic material and banned related hashtags and query recommendations. The organization stated it was dedicated to keeping the platform safe and allocating resources in enhancing compliance measures.
Online Marketplace Operations
Investigations also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of weight loss, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, health issues or previous experience.
Item Information and Costs
Within these communities, messages show dark colored parcels with Royal Mail stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they cannot confirm. Although the research behind retatrutide is sound, these digital products may not contain what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has already seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to possibly serious medical dangers”.
